CRISPR Therapeutics AG reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug
SEC filing record 1 source field available
Fiscal year end
31 December
CRISPR Therapeutics AG has filed 853 SEC EDGAR filings since 13 May 2016

SEC filing history

Showing 576-600 of 853 matching filings.

Per page
25
Current page
24
4/A

4/A filing

Filing date
18 Jan 2019
Reporting date
18 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jan 2019
Reporting date
08 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Dec 2018
Reporting date
26 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89674

SCHEDULE 13D, AMENDMENT NO. 2

Filing date
28 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Dec 2018
Reporting date
21 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89674

SC 13D/A FOR VERTEX PHARMACEUTICALS INC / MA

Filing date
26 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
21 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89674

SCHEDULE 13D

Filing date
21 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2018
Reporting date
01 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37923

CT ORDER filing

Filing date
30 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
09 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221491

424B5

Filing date
09 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
10 Oct 2018
Reporting date
10 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221491

424B5

Filing date
24 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
24 Sep 2018
Reporting date
24 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
21 Sep 2018
Reporting date
19 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-227427

424B5

Filing date
21 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-227427

424B5

Filing date
19 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-227427

S-3ASR

Filing date
19 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .